337 related articles for article (PubMed ID: 18718149)
21. Factors associated with coverage in community-directed treatment with ivermectin for onchocerciasis control in Oyo State, Nigeria.
Brieger WR; Otusanya SA; Oke GA; Oshiname FO; Adeniyi JD
Trop Med Int Health; 2002 Jan; 7(1):11-8. PubMed ID: 11851950
[TBL] [Abstract][Full Text] [Related]
22. Mectizan as a stimulus for development of novel partnerships: the international organization's perspective.
Etya'alé DE
Ann Trop Med Parasitol; 1998 Apr; 92 Suppl 1():S73-7. PubMed ID: 9861271
[TBL] [Abstract][Full Text] [Related]
23. African Programme for Onchocerciasis Control: meeting of National Onchocerciasis Task Forces, September 2012.
Wkly Epidemiol Rec; 2012 Dec; 87(49/50):494-502. PubMed ID: 23311005
[No Abstract] [Full Text] [Related]
24. Public-private partnerships in neglected tropical disease control: the role of nongovernmental organisations.
Bush S; Hopkins AD
Acta Trop; 2011 Sep; 120 Suppl 1():S169-72. PubMed ID: 21470555
[TBL] [Abstract][Full Text] [Related]
25. Influence of health education on community participation in rapid assessment of onchocerciasis prior to distribution of ivermectin.
Shu EN; Nwadike KI; Onwujekwe EO; Ugwu OC; Okonkwo PO
East Afr Med J; 1999 Jun; 76(6):320-3. PubMed ID: 10750518
[TBL] [Abstract][Full Text] [Related]
26. The geographic distribution of onchocerciasis in the 20 participating countries of the African Programme for Onchocerciasis Control: (2) pre-control endemicity levels and estimated number infected.
Zouré HG; Noma M; Tekle AH; Amazigo UV; Diggle PJ; Giorgi E; Remme JH
Parasit Vectors; 2014 Jul; 7():326. PubMed ID: 25053392
[TBL] [Abstract][Full Text] [Related]
27. African Programme for Onchocerciasis Control: meeting of National Task Forces, September 2011.
Wkly Epidemiol Rec; 2011 Nov; 86(48):541-9. PubMed ID: 22128386
[No Abstract] [Full Text] [Related]
28. [Evaluation on implementation of the African programme for onchocerciasis control in Nigeria].
Xie Z; Nsofor I; Tolhurst R
Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Jun; 44(3):403-6. PubMed ID: 22692311
[TBL] [Abstract][Full Text] [Related]
29. Can ivermectin mass treatments eliminate onchocerciasis in Africa?
Winnen M; Plaisier AP; Alley ES; Nagelkerke NJ; van Oortmarssen G; Boatin BA; Habbema JD
Bull World Health Organ; 2002; 80(5):384-91. PubMed ID: 12077614
[TBL] [Abstract][Full Text] [Related]
30. Gender issues in the community-directed treatment with ivermectin (CDTI) of the African Programme for Onchocerciasis Control (APOC).
Clemmons L; Amazigo UV; Bissek AC; Noma M; Oyene U; Ekpo U; Msuya-Mpanju J; Katenga S; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S59-74. PubMed ID: 12081252
[TBL] [Abstract][Full Text] [Related]
31. Special intervention zones.
Yaméogo L
Ann Trop Med Parasitol; 2008 Sep; 102 Suppl 1():23-4. PubMed ID: 18718150
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of measuring compliance to annual ivermectin treatment in the African Programme for Onchocerciasis Control.
Brieger WR; Okeibunor JC; Abiose AO; Ndyomugyenyi R; Kisoka W; Wanji S; Elhassan E; Amazigo UV
Trop Med Int Health; 2007 Feb; 12(2):260-8. PubMed ID: 17300634
[TBL] [Abstract][Full Text] [Related]
33. A method to determine the coverage of ivermectin distribution in onchocerciasis-control programmes.
Schwartz EC; Renk J; Hopkins AD; Huss R; Foster A
Ann Trop Med Parasitol; 1998 Oct; 92(7):793-6. PubMed ID: 9924537
[TBL] [Abstract][Full Text] [Related]
34. A model for evaluating the sustainability of community-directed treatment with ivermectin in the African Program for Onchocerciasis Control.
Okeibunor J; Bump J; Zouré HG; Sékétéli A; Godin C; Amazigo UV
Int J Health Plann Manage; 2012; 27(3):257-71. PubMed ID: 22711222
[TBL] [Abstract][Full Text] [Related]
35. Rapid epidemiological mapping of onchocerciasis (REMO): its application by the African Programme for Onchocerciasis Control (APOC).
Noma M; Nwoke BE; Nutall I; Tambala PA; Enyong P; Namsenmo A; Remme J; Amazigo UV; Kale OO; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S29-39. PubMed ID: 12081248
[TBL] [Abstract][Full Text] [Related]
36. Monitoring community-directed treatment programmes for sustainability: lessons from the African Programme for Onchocerciasis Control (APOC).
Amazigo UV; Obono M; Dadzie KY; Remme J; Jiya J; Ndyomugyenyi R; Roungou JB; Noma M; Sékétéli A
Ann Trop Med Parasitol; 2002 Mar; 96 Suppl 1():S75-92. PubMed ID: 12081253
[TBL] [Abstract][Full Text] [Related]
37. African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan).
Dimomfu BL; Lubeji DK; Noma M; Sékétéli A; Boussinesq M;
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):674-9. PubMed ID: 17433391
[TBL] [Abstract][Full Text] [Related]
38. Contribution and performance of female Community-Directed Distributors in the treatment of onchocerciasis with Ivermectin in Sub-Saharan Africa: a systematic review.
Vouking MZ; Tamo VC; Tadenfok CN
Pan Afr Med J; 2015; 20():188. PubMed ID: 26430485
[TBL] [Abstract][Full Text] [Related]
39. [Parnerships and the distribution of Mectizan. The example of the onchocerciasis control program].
Mariko S
Sante; 1998; 8(1):64-5. PubMed ID: 9592885
[No Abstract] [Full Text] [Related]
40. African Programme For Onchocerciasis Control 1995-2015: model-estimated health impact and cost.
Coffeng LE; Stolk WA; Zouré HG; Veerman JL; Agblewonu KB; Murdoch ME; Noma M; Fobi G; Richardus JH; Bundy DA; Habbema D; de Vlas SJ; Amazigo UV
PLoS Negl Trop Dis; 2013; 7(1):e2032. PubMed ID: 23383355
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
